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O
nce, we thought we understood 
all there was to know about how 
gene expression is regulated: A 
cell can tinker with the expression level of 
a given protein’s messenger RNA by mod-
ifying the activity, abundance, and type of 
transcription factors in the nucleus or with 
the RNA’s stability once it is made. But 
then came a surprising story about a short 
RNA in C. elegans called lin-4, which 
didn’t encode a protein but prevented 
expression of the protein encoded by 
another gene, lin-14, through antisense 
binding to lin-14 mRNA (1, 2). Today, we 
know that lin-4 was just the fi rst example 
of a large number of small RNAs, called 
microRNAs, which regulate the expression 
of various other proteins in a similar way.
Victor Ambros, whose lab published 
that fi rst story about lin-4, has been study-
ing microRNAs (3, 4) and their regulation 
(5, 6) ever since, pushing forward our 
understanding of this pow-
erful mechanism. We called 
him at his offi ce at the Uni-
versity of Massachusetts 
Medical School to get some 
perspective on microRNAs 
and his career and to learn 
about some of the latest 
developments in his lab.
FROM FARM TO LAB TABLE
How did you end up doing a PhD with 
David Baltimore?
I was the fi rst scientist in my family. My 
dad was an immigrant from Poland. He 
came to the States just after World War II 
and met my mom. They got married, 
moved to a farm in Vermont, and started 
farming. My siblings and I grew up 
amongst the cows and pigs and helped with 
the haying and cutting corn, stuff like that.
When I was about nine, I got interested 
in science, and after that I always wanted to 
be a scientist. I was an amateur astronomer; 
I built a telescope and started to imagine that 
I could actually do astronomy or physics 
as an occupation. But I quickly changed 
my mind when I reached college, in part 
because I realized that my math skills weren’t 
really up to the task of being a physicist and 
also because I discovered molecular biology 
and genetics and just fell in love with both 
subjects. David taught one of the advanced 
biology classes I took as an undergraduate at 
MIT, and that probably had some infl uence 
on my decision to work with him.
After college, I worked as a technician 
in David’s lab for a year. I liked it a lot 
and stayed on in his lab when I entered 
graduate school at MIT. I was lucky be-
cause I had gotten a little bit of traction on 
a project and continued on that as a grad 
student, so I ended up fi nishing grad 
school fairly effi ciently.
What did you work on?
I was working on poliovirus. David had a 
nice group of people working on this little 
virus at the time, and there were two 
terrifi c senior postdocs that I learned a 
ton from—Ralph Patterson 
and Bert Flanegan. They 
were really, really expert 
in what they did and very 
enthusiastic about it. I dis-
covered that I didn’t neces-
sarily have to be a genius 
to make progress, if I was 
lucky enough to find my-
self amongst smart, accom-
plished, and enthusiastic people. There 
have been many people like that in my 
career, including my wife, Rosalind Lee, 
who works in my lab and has contributed 
an enormous amount to my success. She 
and a postdoc in my lab, Rhonda Fein-
baum, were the ones who cloned and 
characterized the fi rst microRNA, lin-4, 
while I was at Dartmouth.
EARLY WORM DAYS
Why did you switch ﬁ elds as a postdoc?
I was trying to fi nish up my graduate work 
when Bob Horvitz arrived to start his lab at 
MIT. He gave a series of talks about his 
research, and I really got excited about the 
opportunity to work on C. elegans, a new 
model organism that had a lot of interesting 
attributes. I imagined that it was simpler 
than Drosophila and was interested in it 
because it followed a very clear develop-
mental program. You could learn a lot from 
genetics studies in this organism, before 
having to resort to the time-consuming and 
diffi cult process of cloning gene products.
Also, this may sound silly, but I was 
really turned on by the idea that you could 
freeze the worms. You could neglect them 
for months and then come back and revive 
your cultures by thawing out the worms. 
There wasn’t the burden of having to main-
tain your fl y strains. So, I could imagine 
that it was a forgiving enough animal that 
it would allow me to do science without 
tripping myself up too badly. [Laughs]
I got excited by some mutants that Bob 
had in the lab at the time, which we later 
called heterochronic mutants. One of 
these mutants was a lin-4 loss of function, 
which repeated early developmental stages 
in many lineages. But Bob also had a lin-14 
loss-of-function mutant that had the 
opposite phenotype, skipping the early 
stages and going right to the later stages. 
So Bob brought these mutants to me and 
suggested I work on them. They were 
immediately captivating.
In the end, I took lin-4 with me to study 
in my own lab, and Gary Ruvkun, who was 
a postdoc in Bob’s lab at the same time as 
me, took lin-14 to his lab. Because they 
were so obviously intertwined, he and I kept 
in close contact about our work.
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Ambros studies how microRNAs impact development.
Victor Ambros:  The broad scope of microRNAs
“That shared 
discovery is 
one of the 
most precious 
moments in 
my career.”
Victor Ambros
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Had you any idea at the time what the 
nature of the lin-4 mutant was?
The assumption was that it was a protein 
product. I mean, nobody ever thought that 
there would be any other kind of regulator. 
There really wasn’t any reason to imagine 
that there were any other kinds of mole-
cules necessary, other than proteins, to 
carry out everything that’s done in a cell—
especially with regard to the regulation of 
gene expression. The complexity of gene 
regulation by proteins alone was so enor-
mous that I never imagined—and nobody 
I knew imagined—that we needed to look 
for new kinds of regulatory molecules.
The realization that lin-4 was antisense 
to the 3-untranslated region of lin-14 was 
totally the result of communication between 
Gary and me. That shared discovery is one 
of the most precious moments in my career. 
But at the time I didn’t realize that this might 
be the fi rst example of a general mechanism 
for regulating gene expression because 
I was prone to thinking that whatever I was 
studying in the worm was not generally 
applicable. It wasn’t until genome sequences 
were made available that the prevalence 
of this mechanism became clear.
THE RIGHT CONTEXT
You’ve moved to studying processes that 
modulate microRNA function…
One protein we’ve studied is called Nhl-2. 
It’s an example of an emerging class of pro-
teins that can modulate, positively or nega-
tively, the RNA-induced silencing com-
plex (RISC) that inhibits mRNAs targeted 
by microRNAs. This class of genes may 
have either general effects on RISC activity 
or, in some cases, more 
specifi c effects. One area of 
interest in the lab right now 
is trying to understand the 
specifi c outcomes for the 
regulation of particular 
microRNAs. Do they al-
ways interact with all their 
targets, or is their activity on 
some targets promoted or 
inhibited at the expense of 
other targets? Can their in-
teraction with certain targets 
be modifi ed depending on 
context? We’re using genet-
ic and genomic approaches 
to identify new modulatory cofactors.
Do defects in microRNA regulation 
have consequences as dramatic as lin-4 
mutations?
Nhl-2 is an example of a protein whose 
null mutation has a very weak phenotype. 
It’s a conserved protein, and there are other 
family members that are similar to it, but if 
you eliminate those at the same time you 
don’t really aggravate its phenotype. So 
what is this protein doing? We found 
that if you compromise 
microRNA activity by 
mutating additional micro-
RNA genes that themselves 
don’t cause a very strong 
phenotype, now the com-
bination with Nhl-2 muta-
tions has a very strong 
phenotype. There’s a kind 
of genetic synergy. This 
could be because they in-
teract with one another or 
because they each con-
tribute in parallel to similar 
outcomes, so the challenge is to fi gure out 
the basis for their synergy.
We’re also trying to understand the 
activity of genes, particularly microRNA 
genes, by exploring what kind of condi-
tions—genetic backgrounds, environmental 
stresses, diets, and so forth—synergisti-
cally affect the phenotype of mutants. 
We’re particularly interested in how 
microRNAs may be involved in mecha-
nisms that buffer development against 
these kinds of stresses. The interface be-
tween developmental regulation of gene 
expression and stress responses is really 
interesting to us. This is important no 
matter what kind of animal you are, and 
I’m excited that the worm offers a particu-
larly appropriate system to explore these 
questions. We think it’ll be fruitful.
Any other projects you can talk about?
Right now, Rosalind is working on a col-
laboration with some colleagues here at 
UMass who are interested 
in using microRNAs as 
biomarkers. MicroRNAs 
are easily assayable in 
bodily fl uids, and, because 
they’re regulators of gene 
expression, they have a 
lot of implicit functional 
import. So, we’re helping 
our colleagues profile 
microRNAs in samples 
of body fl uids from pa-
tients with a variety of 
indications. It’s a bit of a 
departure for my lab but an interesting 
fi eld for us to get into.
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“The interface 
between 
developmental 
regulation of 
gene expression 
and stress 
responses is 
really interesting 
to us.”
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Victor Ambros works closely with his wife, 
Rosalind Lee.
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Expression of col-19::GFP (green) is regulated by the lin-4 and 
let-7 microRNAs.
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